Priority Review in Merkel Cell Carcinoma, Breakthrough Designation in RET-Altered Cancers, and More
2 مناظر
• 07/17/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
Gina Columbus reports on a priority review designation in Merkel cell carcinoma, a breakthrough therapy designation in select RET-altered cancers, an application submitted in pediatric ALL, and European approvals in multiple myeloma, melanoma, and ALL.
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے